Runx3 is required for full activation of regulatory T cells to prevent colitis-associated tumor formation

Journal of Immunology

Volumn 186, Issue 11, 2011, Pages 6515-6520

  Sugai, Manabu ^a   Aoki, Koji ^b   Osato, Motomi ^c,d,e,f   Nambu, Yukiko ^a   Ito, Kosei ^g   Taketo, Makoto M ^b   Shimizu, Akira ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^g NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL TRANSFER; COLITIS; COLON TUMOR; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENE ACTIVATION; LIVER CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COLITIS; COLON; COLONIC NEOPLASMS; CORE BINDING FACTOR ALPHA 3 SUBUNIT; FEMALE; FLOW CYTOMETRY; GASTRITIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79958027367     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001671     Document Type: Article

References (31)

1. Waldner, M. J., and M. F. Neurath. 2009. Colitis-associated cancer: the role of T cells in tumor development. Semin. Immunopathol. 31: 249-256.
2. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
3. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet 357: 539-545.
4. Karin, M., T. Lawrence, and V. Nizet. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124: 823-835. (Pubitemid 43261455)
5. Garrett, W. S., G. M. Lord, S. Punit, G. Lugo-Villarino, S. K. Mazmanian, S. Ito, J. N. Glickman, and L. H. Glimcher. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131: 33-45.
6. Kosmaczewska, A., L. Ciszak, S. Potoczek, and I. Frydecka. 2008. The significance of Treg cells in defective tumor immunity. Arch. Immunol. Ther. Exp. (Warsz.) 56: 181-191.
7. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L. Sun, J. Lutterbaugh, R. S. Fan, E. Zborowska, K. W. Kinzler, B. Vogelstein, et al. 1995. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
8. Takaku, K., M. Oshima, H. Miyoshi, M. Matsui, M. F. Seldin, and M. M. Taketo. 1998. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92: 645-656.
9. Kim, B. G., C. Li, W. Qiao, M. Mamura, B. Kasprzak, M. Anver, L. Wolfraim, S. Hong, E. Mushinski, M. Potter, et al. 2006. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441: 1015-1019. (Pubitemid 43980359)
10. Shi, M. J., and J. Stavnezer. 1998. CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter. J. Immunol. 161: 6751-6760. (Pubitemid 28562218)
11. Zhang, Y., and R. Derynck. 2000. Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275: 16979-16985.
12. Pardali, E., X. Q. Xie, P. Tsapogas, S. Itoh, K. Arvanitidis, C. H. Heldin, P. ten Dijke, T. Grundström, and P. Sideras. 2000. Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germline IgA genes. J. Biol. Chem. 275: 3552-3560.
13. Hanai, J., L. F. Chen, T. Kanno, N. Ohtani-Fujita, W. Y. Kim, W. H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M. J. Shi, et al. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274: 31577-31582.
14. Taniuchi, I., M. Osato, T. Egawa, M. J. Sunshine, S. C. Bae, T. Komori, Y. Ito, and D. R. Littman. 2002. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111: 621-633.
15. Sato, T., S. Ohno, T. Hayashi, C. Sato, K. Kohu, M. Satake, and S. Habu. 2005. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity 22: 317-328. (Pubitemid 40387474)
16. Ohno, S., T. Sato, K. Kohu, K. Takeda, K. Okumura, M. Satake, and S. Habu. 2008. Runx proteins are involved in regulation of CD122, Ly49 family and IFNgamma expression during NK cell differentiation. Int. Immunol. 20: 71-79.
17. Kohu, K., T. Sato, S. Ohno, K. Hayashi, R. Uchino, N. Abe, M. Nakazato, N. Yoshida, T. Kikuchi, Y. Iwakura, et al. 2005. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J. Immunol. 174: 2627-2636. (Pubitemid 40279676)
18. Fainaru, O., E. Woolf, J. Lotem, M. Yarmus, O. Brenner, D. Goldenberg, V. Negreanu, Y. Bernstein, D. Levanon, S. Jung, and Y. Groner. 2004. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J. 23: 969-979. (Pubitemid 38418763)
19. Watanabe, K., M. Sugai, Y. Nambu, M. Osato, T. Hayashi, M. Kawaguchi, T. Komori, Y. Ito, and A. Shimizu. 2010. Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling. J. Immunol. 184: 2785-2792.
20. Li, Q. L., K. Ito, C. Sakakura, H. Fukamachi, K. Inoue, X. Z. Chi, K. Y. Lee, S. Nomura, C. W. Lee, S. B. Han, et al. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124. (Pubitemid 34327521)
21. Ito, K., A. C. Lim, M. Salto-Tellez, L. Motoda, M. Osato, L. S. Chuang, C. W. Lee, D. C. Voon, J. K. Koo, H. Wang, et al. 2008. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14: 226-237.
22. Brenner, O., D. Levanon, V. Negreanu, O. Golubkov, O. Fainaru, E. Woolf, and Y. Groner. 2004. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl. Acad. Sci. USA 101: 16016-16021.
23. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066. (Pubitemid 30398356)
24. Gonda, H., M. Sugai, Y. Nambu, T. Katakai, Y. Agata, K. J. Mori, Y. Yokota, and A. Shimizu. 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198: 1427-1437.
25. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
26. Gondek, D. C., L. F. Lu, S. A. Quezada, S. Sakaguchi, and R. J. Noelle. 2005. Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174: 1783-1786.
27. Bruno, L., L. Mazzarella, M. Hoogenkamp, A. Hertweck, B. S. Cobb, S. Sauer, S. Hadjur, M. Leleu, Y. Naoe, J. C. Telfer, et al. 2009. Runx proteins regulate Foxp3 expression. J. Exp. Med. 206: 2329-2337.
28. Rudra, D., T. Egawa, M. M. Chong, P. Treuting, D. R. Littman, and A. Y. Rudensky. 2009. Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10: 1170-1177.
29. Klunker, S., M. M. Chong, P. Y. Mantel, O. Palomares, C. Bassin, M. Ziegler, B. Rückert, F. Meiler, M. Akdis, D. R. Littman, and C. A. Akdis. 2009. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med. 206: 2701-2715.
30. Kitoh, A., M. Ono, Y. Naoe, N. Ohkura, T. Yamaguchi, H. Yaguchi, I. Kitabayashi, T. Tsukada, T. Nomura, Y. Miyachi, et al. 2009. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity 31: 609-620.
31. Ono, M., H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y. Miyachi, T. Tsukada, and S. Sakaguchi. 2007. Foxp3 controls regulatory Tcell function by interacting with AML1/Runx1. Nature 446: 685-689. (Pubitemid 46606883)